Veristat Congratulates Alnylam on the FDA Approval of ONPATTRO™
Continues Collaboration to Provide Regulatory Submission Support for Additional Patisiran Submissions
SOUTHBOROUGH, MA – August 20, 2018...
Veristat Congratulates Agios on the FDA Approval of TIBSOVO®
The First Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH1 Mutation
SOUTHBOROUGH, MA –...